Blog Archives RSS Statement

Lemtrada™ (alemtuzumab)

MSC Disclaimer

Avonex FDA- approved

Rebif (interferon-beta-1a) FDA-approved

Tysabri (natalizumab) approved for MS

Gilenya (fingolimod) FDA approved

Alemtuzumab (CAMPATH)

Rituximab (Rituxan)

Management of Relapses in MS

Treatment of symptoms in MS

Why do people get MS?

Testing for multiple sclerosis

Disclosure RSS Statement

Most of the information found on this website comes from RSS Feeds. It is an automated task that provides the information to you. We try to limit items that are duplicates, but with many feeds this can be difficult. Since the owner of this website also has MS and is legally blind this service was necessary to keep the website running with as much automation as possible. Volunteers help from time to time but many have disabilities themselves. We thank you for visiting us and hope that MSC can be of service to you and your loved ones.